These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 66859)

  • 1. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of escape from immune surveillance.
    Klein G
    Natl Cancer Inst Monogr; 1976 Nov; 44():135-6. PubMed ID: 193018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic specificity of cell-mediated antitumor reaction in the MSV system.
    Leclerc JC; Gomard E; Levy JP; Senik A
    Bibl Haematol; 1975 Oct; (43):173-6. PubMed ID: 60997
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro interactions between tumor cells and immune lymphoid cells.
    Levy JP; Gomard E; Senik A; Leclerc JC
    Recent Results Cancer Res; 1976; (56):24-30. PubMed ID: 188084
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E; Duprez V; Henin Y; Levy JP
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 13. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 14. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells.
    Hunsmann G; Weiland E; Mussgay M; Schneider J
    J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine sarcoma virus defectiveness. Viral polymerase expression murine and nonmurine host cells transformed by S+L-type murine sarcoma virus.
    Peeples PT; Gerwin BI; Papageorge AG; Smith SG
    Virology; 1975 Oct; 67(2):344-55. PubMed ID: 52940
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent progress in studies of mouse type-C viruses.
    Sarma PS; Gazdar AF
    Curr Top Microbiol Immunol; 1974; (68):1-28. PubMed ID: 4375018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
    Levy JP; Kourilsky FM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 19. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
    Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
    Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responsiveness in rats infected with the Soehner-Dmochowski murine sarcoma virus (MSV-SD).
    Evans DL; Barnett JW; Dmochowski L
    Tex Rep Biol Med; 1974; 32(2):449-60. PubMed ID: 4372740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.